Home › Funds › Temasek Holdings (Private) Ltd › ONC
Temasek Holdings (Private) Ltd position in ONC
BEONE MEDICINES LTD · Health Care
Temasek Holdings (Private) Ltd reported holding 845,729 shares of ONC (BEONE MEDICINES LTD) in its Q2 2026 13F filing — a position valued at US$241.0M, representing 0.75% of its reported portfolio and ranking #28 among its reported holdings. Temasek Holdings (Private) Ltd has disclosed ONC holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Temasek Holdings (Private) Ltd's ONC position evolved
Temasek Holdings (Private) Ltd first disclosed a stake in ONC in Q3 2023 at 3,014,171 shares (US$542.2M). The position peaked in Q4 2023 at 3,014,171 shares, worth US$543.6M. Across 12 filings, Temasek Holdings (Private) Ltd increased the stake 1 time(s), trimmed it 6 time(s) and left it unchanged 4 time(s). The most recent filing (Q2 2026) shows 845,729 shares valued at US$241.0M — a reduction of -16,914 shares quarter over quarter.. Notable position changes include a 36% trim in Q4 2024 (shares rose 47% over the following quarter), a 35% trim in Q1 2025 (shares fell 11% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 3.01M | $542.16M | New |
| Q4 2023 | 3.01M | $543.64M | Hold |
| Q1 2024 | 3.01M | $471.39M | Hold |
| Q2 2024 | 3.01M | $430.03M | Hold |
| Q3 2024 | 2.39M | $536.26M | Reduce |
| Q4 2024 | 1.53M | $281.74M | Reduce |
| Q1 2025 | 993.75K | $270.47M | Reduce |
| Q2 2025 | 1.01M | $244.60M | Add |
| Q3 2025 | 1.01M | $344.61M | Hold |
| Q4 2025 | 919.59K | $279.38M | Reduce |
| Q1 2026 | 862.64K | $256.18M | Reduce |
| Q2 2026 | 845.73K | $241.01M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ONC and 13F data
ONC (BEONE MEDICINES LTD) is a Health Care company. 28 other funds we track also report a position in ONC — the largest reported positions include BAKER BROS. ADVISORS LP (US$2.51B), PRIMECAP MANAGEMENT CO/CA/ (US$1.43B), Temasek Holdings (US$241.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ONC
- BAKER BROS. ADVISORS LP 8.80M sh · $2.51B · Q2 2026
- PRIMECAP MANAGEMENT CO/CA/ 5.01M sh · $1.43B · Q2 2026
- Temasek Holdings 845.73K sh · $241.01M · Q2 2026
- Siren, L.L.C. 465.00K sh · $132.51M · Q2 2026
- Capital International, Inc./CA/ 305.48K sh · $87.05M · Q2 2026
- Capital International Sarl 175.54K sh · $50.02M · Q2 2026
More on Temasek Holdings (Private) Ltd
FAQ
How long has Temasek Holdings (Private) Ltd held ONC?
Temasek Holdings (Private) Ltd has disclosed ONC holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Temasek Holdings (Private) Ltd's current position in ONC?
As of Q2 2026, Temasek Holdings (Private) Ltd holds 845.73K shares of ONC (BEONE MEDICINES LTD), valued at $241.01M, representing 0.75% of its reported portfolio and ranking #28.
Has Temasek Holdings (Private) Ltd been buying or selling ONC?
In the latest 13F filing (Q2 2026), Temasek Holdings (Private) Ltd reduced its position in ONC. The position peaked in Q4 2023 at 3.01M shares.
Which other funds hold ONC?
Other major institutional holders of ONC include BAKER BROS. ADVISORS LP, PRIMECAP MANAGEMENT CO/CA/, Temasek Holdings, among 28 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.